Transgenic animals give investigators a powerful system for either targeting the expression of a gene to a specific tissue(s) or obliterating the expression of a specific gene. Therefore, transgenic animals are an excellent tool for directly evaluating the role of a specific gene (or genes) in an age-related disease or in aging. The Transgenic Core will provide all services and services and resources required to produce transgenic mice, transgenic rats, and transgenic mice with gene knockouts for Center investigators. Because the techniques for producing transgenic rats or mice with gene knockouts are not currently available at UTHSC-SA, an important goal of this Core is to develop these techniques.
The specific aims of the Core are as follow: 1. To produce transgenic mice by microinjection and to identify the transgenic mice by PCR and DNA hybridization techniques. The number and integration sites of the transgene also will be determined by examining DNA from the transgenic mice. 2. To develop the techniques for producing transgenic rats by microinjection and to use these techniques to produce transgenic rats for Center investigators. Transgenic rats will be identified by PCR and DNA hybridization techniques, and the number and integration sites of the transgene will be determined. 3. To develop the techniques for producing transgenic mice with gene knockouts using homologous recombination and to use these techniques to produce transgenic knockout mice for Center investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013319-05
Application #
6201044
Study Section
Project Start
1999-08-01
Project End
2000-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Kang, Donghoon; Kirienko, Daniel R; Webster, Phillip et al. (2018) Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence 9:804-817
Hook, Michael; Roy, Suheeta; Williams, Evan G et al. (2018) Genetic cartography of longevity in humans and mice: Current landscape and horizons. Biochim Biophys Acta Mol Basis Dis 1864:2718-2732
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918

Showing the most recent 10 out of 231 publications